The Personalized Medicine Market size is expected to grow at an annual average of 10% during 2021-2027. Advances in science and technology, especially the way we explain diseases, develop drugs, and recommend treatments, are changing. The concept of personalized medicine has emerged over the past decade with advances in genomic and protein science, which has led to “targeted” diagnostics that influence knowledge of an individual’s genetic makeup to construct more personalized approaches to health care. and the development of therapeutics. .
(Get 15% Discount on Buying this Report)
A full report of Personalized Medicine Market is available at: https://www.orionmarketreports.com/personalized-medicine-market/28258/
The following segmentation are covered in this report:
By Technology
- Big Data Analytics
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Companion Diagnostics
- Others
By Disease Area
- Oncology
- Respiratory Diseases
- Central Nervous System Disorders
- Immunology
- Genetic Diseases
- Others
Company Profile
- Illumina, Inc.
- GE Healthcare
- Danaher Corporation (Cepheid, Inc.)
- Abbott
- QIAGEN
- Exact Sciences Corporation
- ASURAGEN, INC.
- Biogen
- Dako A/S
The report covers the following objectives:
- Proliferation and maturation of trade in the global Personalized Medicine Market
- The market share of the global Personalized Medicine Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Personalized Medicine Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Personalized Medicine Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
